Skip to main content
  • Advertise
    Want to Advertise with Us?
    Conquer welcomes advertising and sponsorship collaborations with reputable companies offering high-quality products and services to people affected by cancer.
  • Affiliated Brands
    Academy of Oncology Nurse & Patient Navigators
    The Academy of Oncology Nurse & Patient Navigators (AONN+) is the largest national specialty organization dedicated to improving patient care and quality of life by defining, enhancing, and promoting the role of oncology nurse and patient navigators. Our organization of over 8,900 members was founded in May 2009 to provide a network for all professionals involved and interested in patient navigation and survivorship care services to better manage the complexities of the cancer care treatment continuum for their patients. We view our organization as one consisting of “professional patient advocates” and, to that end, we support and serve our members.
    Journal of Oncology Navigation & Survivorship
    The Journal of Oncology Navigation & Survivorship (JONS) promotes reliance on evidence-based practices in navigating patients with cancer and their caregivers through diagnosis, treatment, and survivorship. JONS also seeks to strengthen the role of nurse and patient navigators in cancer care by serving as a platform for these professionals to disseminate original research findings, exchange best practices, and find support for their growing community.
    The Oncology Nurse-APN/PA
    The Oncology Nurse-APN/PA (TON) provides coverage of the wide spectrum of oncology-related events, trends, news, therapeutics, diagnostics, organizations, and legislation that directly affect hematology/oncology nurses and advanced practitioners involved in healthcare delivery and product utilization. The scope and coverage include a unique presentation of news and events that are shaping the care of patients with cancer.
  • Healthcare Providers
  • Contribute

Multiple Myeloma

Opportunities for Improving the Care of Patients with Multiple Myeloma
This article summarizes the views of the patients regarding their experiences with current treatments and other issues related to cancer care. Read More ›

Advances in Multiple Myeloma Treatment
This special feature provides information for patients about oral medications for the treatment of multiple myeloma. Read More ›

Oral Therapies in Multiple Myeloma: Working with Your Oncology Care Team for Best Outcomes
Over the past 10 years, treatment options for patients with multiple myeloma have increased dramatically. These advances have resulted in improved survival rates for patients and an increased focus on the patient’s quality of life that have fueled the important development and use of oral treatments in recent years, a trend that is expected to continue. Read More ›

Patient Perspective: Critical Factors in Improving Patients’ Adherence to Oral Medications
Now more than ever, patients with multiple myeloma have unprecedented numbers of treatment options to choose from for their deadly plasma-cell neoplastic diseases. Read More ›

Nurse Navigator Perspective: The Patient’s Role in Adhering to Oral Therapies
Instead of receiving cancer treatments in a hospital or outpatient setting, many patients are now being treated in the comfort of their own home with oral pills that they administer themselves. Read More ›

Waging Hope for Pancreatic Cancer
I first met Maurice Bason at a Pancreatic Cancer Action Network (PanCAN) support group meeting, which I attended in support of my sister Diane. Read More ›

Finding Hope for Multiple Myeloma through a Clinical Trial
The following section features a selection of patient stories submitted to the 2015 Hero of Hope™ Patient Award. These stories illustrate the range of extraordinary patient profiles submitted by patients, family members, friends, and healthcare providers. Read More ›

New Treatment Options for Patients with Multiple Myeloma on the Rise
In September 2015, the biannual International Myeloma Workshop was held in Rome, Italy, to provide physicians and nurses up-to-date information on new therapies for patients with multiple myeloma. Read More ›

Elotuzumab, First-in-Class Monoclonal Antibody Immuno­­therapy, Improves Outcomes in Patients with Multiple Myeloma
“This therapy is an innovative approach, one that combines the precision of a targeted, immune-based therapy with traditional myeloma therapy. The results are very encouraging, giving renewed hope to patients who have relapsed,” says ASCO President-Elect Julie M. Vose, MD, MBA, Chief of the Division of Oncology/Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha. Read More ›

It's Our Cancer
Brenda and her son, Steve, share their respective stories as Brenda deals with a multiple myeloma diagnosis. Read More ›

Page 9 of 10